Angry@Arthritis

Dr. Roach provides the 411 on the U.S. Department of Defense new $10 million Arthritis Research Program – part of Uncle Sam’s broader war on OA. To learn more about the Defense CDMRP Arthritis Research Program visit https://cdmrp.health.mil/atrp/default.

Ivan’s team is pioneering a cure for OA – and has successfully treated multiple joints in humans. What is N-TEC? How does it work? When is it coming to America and how can I sign up? Read more about the research – https://biomedizin.unibas.ch/en/research/research-groups/martin-lab/cartilage-repair/.

Ben and his team have created synthetic cartilage that’s stronger and more slippery than the natural stuff. They’ve tested it in large animals – and are heading into human trials. What is Galene? How does it work? What are the pros and cons of a synthetic approach? What’s the status of the trials and what’s the timeline to the patients? Read more about the research – https://www.spartabiomedical.com.

Rep. Connolly gets real about America’s OA plight and brings the cure opportunity front and center. He covers his personal arthritis journey, the beauty of the new OA Fix Chart, ARPA-H NITRO, and Congress responsibility to get serious about funding OA cures for America.

Jennifer tells us that we can regrow cartilage today – but, that’s not enough. She leads us on a gallop through the emerging science in regenerative immunology – exploring how the body can heal itself. Learn about senescent zombie cells; the rise, fall, and potential of Unity BioTech’s innovative drug UBX0101; and hear about the path forward for NITRO – the U.S. Federal government’s five-year moonshot to cure OA, and more.

Martin and his team have a possible OA drug waiting on the sidelines for lift off. It’s tested in large animals – and ready for human clinical trials. Learn more about R399E, the development journey – and the potential. Want more – go deeper.